Abstract
Angiogenesis is a fundamental biologic process which plays a pivotal role in development, pathologic states and physiologic responses. In the developing embryo, blood vessels form by two mechanisms: (1) vasculogenesis, in which mesoderm-derived angioblasts migrate to specific sites in the embryo and form a network of vascular cords, and (2) angiogenesis, which occurs primarily during organogenesis, and is characterized by the sprouting of new vessels from the established cords into previously avascular organ rudiments [1, 2]. Soluble angiogenesis factor or factors deposited in the extracellular matrix may act to stimulate and direct this neovascularization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Poole TJ, Coffin JD (1989) Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. J Exp Zool 251:224–231.
Risau W, Lemmon V (1988) Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 125:441–450.
Folkman J (1974) Tumor angiogenesis. Adv Cancer Res 10:331–358.
Moscatelli D, Joseph-Silverstein J, Presta M, Rifkin DB (1988) Multiple forms of an angiogenesis factor: basic fibroblast growth factor. Biochimie 70:83–87.
Baird A, Walicke PA (1989) Fibroblast growth factors. Br Med Bull 45:438–452.
Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309–1312.
Ziche M, Jones J, Gullino PM. (1982) Role of prostaglandin E1 and copper in angiogenesis. JNCI 69:475–482.
Weiss JB, Brown RA, Kumar S, Phillips P (1979) An angiogenic factor isolated from tumours. A potent low molecular weight compound. Br J Cancer 40:493–496.
Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24:5480–5486.
Redmer DA, Grazul AT, Kirsch JD, Reynolds LP (1988) Angiogenic activity of bovine corpora lutea at several stages of luteal development. J Reprod Ferti 82:627–634.
Gospodarowicz D, Thakral KK (1977) Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. Proc Natl Acad Sci, USA 75:847–851.
Reynolds LP, Millaway DS, Kirsch JD, Infeld JE, Redmer DA (1987) Angiogenic activity of placental tissues of cows. J Reprod Ferti 81:233–240.
Reynolds LP, Reder DA (1988) Secretion of angiogenic activity by placental tissues of cows at several stages of gestation. J Reprod Ferti 83:497–502.
Burgos H (1986) Angiogenic factor from human term placenta. Purification and partial characterization. Eur J Clin Invest 16:486–493.
Moscatelli D, Presta M, Rifkin DB (1986) Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci USA 83:2091–2095.
Phillips GD, Fiegel VD, Knighton DR (1992) Putative angiogenesis factors: A review. Wounds 4:94–107.
Ausprunk DH, Folkman J (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14:53–65.
Burger PC, Chandler DB, Klintworth GK (1983) Corneal neovascularization as studied by scanning electron microscopy of vascular casts. Lab Invest 48:169–180.
Burger PC, Chandler DB, Klintworth GK (1984) Scanning electron microscopy of vascular casts. J Electron Microsc Techn 1:341–348.
Phillips GD, Whitehead RA, Knighton DR (1991) Inititation and pattern of angiogenesis in wound healing in the rat. Am J Anat 192:257–262.
Knighton DR, Fiegel VD, Austin LL, Ciresi KF, Butler EL (1986) Classification and treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 204:322–330.
Roberts A, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS (1986) Transforming growth factor type B: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167–4171.
Gimbrone MA Jr, Cotran R, Leapman SB, Folkman J (1974) Tumor growth and neovas-cularization: an experimental model using the rabbit cornea JNCI 52:413–427.
Phillips GD, Whitehead RA, Stone AM, Ruebel MW, Goodkin ML, Knighton DR (1994) Transforming growth factor beta (TGF-β) stimulation of angiogenesis: an electron microscopic study. J Submicrosc Cytol Pathol 25:149–155.
Phillips GD, Whitehead RA, Knighton DR (1992) Inhibition by methylprednisolone acetate suggests an indirect mechanism for TGF-B induced angiogenesis. Growth Factors 6:77–84.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Knighton, D.R., Fiegel, V.D., Phillips, G.D. (1995). Growth Factor Control of Wound Healing Angiogenesis. In: Altmeyer, P., Hoffmann, K., el Gammal, S., Hutchinson, J. (eds) Wound Healing and Skin Physiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77882-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-77882-7_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56124-8
Online ISBN: 978-3-642-77882-7
eBook Packages: Springer Book Archive